Delivery Order SPE2DX22D0010-SPE2D825FHL74
Award Date 8/6/25
Potential Completion Date 8/7/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- This delivery order, awarded on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides Oxymorphone HCL ER Tablets 40mg with a ceiling value of $2,062.57. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets (60-count packages) with a ceiling value of $2,869.54. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a $2,981.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count) on September 19, 2025, with completion targeted for September 22, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,276.50 firm fixed price delivery order is for the supply of Oxymorphone HCL ER Tablets 15mg, a pain management medication. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This delivery order, awarded on July 23, 2025, authorizes AmerisourceBergen Drug Corp to supply Oxymorphone HCL ER Tablets 20mg to the Medical Supply Chain, a Defense Logistics Agency organization supporting the Department of Defense. The contract, with a ceiling value of $12,252.12 and a firm fixed price structure, represents a non-competitive set-aside delivery against a larger federal contract vehicle. Performance is scheduled for completion by July 24, 2025, with fulfillment occurring at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,327.10 delivery order contract is for the supply of 30mg Oxymorphone HCL ER tablets, a pain management medication. The contract has an August 2023 completion date and is a firm fixed-price arrangement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
- On June 16, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for completion by June 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,150.95, is for the delivery of Oxymorphone HCL ER 20 mg tablets. The contract has an ultimate completion date of April 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...